Viemed Healthcare Inc Cash Flow Conversion Efficiency
Viemed Healthcare Inc cash flow conversion efficiency. Based on the latest financial reports, Viemed Healthcare Inc (VMD) has a cash flow conversion efficiency ratio of 0.136x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($18.37 Million) by net assets ($135.50 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Viemed Healthcare Inc (2014–2024)
Cash flow conversion efficiency of Viemed Healthcare Inc from 2014 to 2024. This chart illustrates how Viemed Healthcare Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Viemed Healthcare Inc (VMD) stock price for real-time trading data and today's change.
Viemed Healthcare Inc Cash Flow Conversion Ratio Explained
Viemed Healthcare Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Viemed Healthcare Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Viemed Healthcare Inc ranked by their cash flow conversion efficiency. Also see VMD stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Companhia Energética do Ceará - Coelce
SA:COCE3
|
-0.085x |
|
Shanghai Trendzone Decor Grp
SHG:603030
|
0.052x |
|
Zhejiang Wanfeng Chemical Co. Ltd. A
SHG:603172
|
N/A |
|
ARTS Group Co Ltd
SHG:603017
|
0.042x |
|
Shanghai Xin Nanyang Co Ltd
SHG:600661
|
-0.043x |
|
Falcon's Beyond Global, Inc. Class A Common Stock
NASDAQ:FBYD
|
0.080x |
|
MVB Financial Corp
NASDAQ:MVBF
|
-0.070x |
|
HCK Capital Group Bhd
KLSE:7105
|
-0.259x |
Annual Cash Flow Conversion Efficiency for Viemed Healthcare Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of Viemed Healthcare Inc from 2014 to 2024. Review VMD FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $133.30 Million | $39.09 Million | 0.293x | -26.13% |
| 2023-12-31 | $113.89 Million | $45.21 Million | 0.397x | +38.90% |
| 2022-12-31 | $97.09 Million | $27.75 Million | 0.286x | +20.47% |
| 2021-12-31 | $94.82 Million | $22.49 Million | 0.237x | -44.80% |
| 2020-12-31 | $81.69 Million | $35.11 Million | 0.430x | -1.60% |
| 2019-12-31 | $43.70 Million | $19.09 Million | 0.437x | -31.59% |
| 2018-12-31 | $35.03 Million | $22.37 Million | 0.638x | +26.08% |
| 2017-12-31 | $23.74 Million | $12.02 Million | 0.506x | +1.69% |
| 2016-12-31 | $12.88 Million | $6.41 Million | 0.498x | -38.15% |
| 2015-12-31 | $11.65 Million | $9.38 Million | 0.805x | -10.57% |
| 2014-12-31 | $8.43 Million | $7.59 Million | 0.900x | -- |
About Viemed Healthcare Inc
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive … Read more